Market Overview

18 Stocks Moving In Thursday's Pre-Market Session

Share:


Gainers

  • Inteliquent Inc (NASDAQ: IQNT) shares rose 37.4 percent to $23.00 in pre-market trading after the company agreed to be acquired by GTCR for $23.00 per share in cash.
  • Actua Corp (NASDAQ: ACTA) shares rose 23.7 percent to $14.35 in pre-market trading after the company posted a narrower-than-expected quarterly loss.
  • Intersect ENT Inc (NASDAQ: XENT) rose 16.8 percent to $9.75 in pre-market trading after the company posted better-than-expected Q3 results.
  • Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) rose 16.3 percent to $3.22 in pre-market trading after the company disclosed its plans for a single Phase III clinical trial for voclosporin in the treatment of lupus nephritis following successful completion of the end of Phase II meeting with the FDA.
  • Qiagen NV (NASDAQ: QGEN) shares rose 10.2 percent to $26.38 in pre-market trading on upbeat quarterly earnings.
  • Omeros Corporation (NASDAQ: OMER) shares rose 9.6 percent to $9.48 in pre-market trading after the company disclosed that it has filed orphan drug application for OMS721 in immunoglobulin A nephropathy
  • Insys Therapeutics Inc (NASDAQ: INSY) rose 9.2 percent to $11.26 in pre-market trading. Insys Therapeutics reported Q3 earnings of $0.00 per share on revenue of $55.2 million.
  • Technical Communications Corporation (NASDAQ: TCCO) rose 8.7 percent to $2.50 in pre-market trading after dropping 2.13 percent on Wednesday.
  • Royal Bank of Scotland Group PLC (NYSE: RBS) rose 7.7 percent to $4.87 in the pre-market trading session after falling 1.74 percent on Wednesday.
  • Depomed Inc (NASDAQ: DEPO) rose 7.2 percent to $24.10 in pre-market trading after declining 0.57 percent on Wednesday.
  • Chesapeake Energy Corporation (NYSE: CHK) rose 5.5 percent to $5.60 in the pre-market trading after the company reported upbeat quarterly earnings.
  • Whole Foods Market, Inc. (NASDAQ: WFM) rose 3.5 percent to $29.50 in pre-market trading after the company reported upbeat earnings for its fourth quarter. The company eliminated its co-CEO structure, and appointed John Mackey as sole CEO.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • Diplomat Pharmacy Inc (NYSE: DPLO) shares fell 33.7 percent to $14.85 in pre-market trading after the company reported downbeat quarterly earnings and lowered its FY16 forecast.
  • Fitbit Inc (NYSE: FIT) shares fell 30 percent to $8.97 in pre-market trading after the company posted downbeat quarterly revenue and issued a weak forecast the current quarter.
  • Credit Suisse Group AG (ADR) (NYSE: CS) shares fell 4.9 percent to $12.92 in pre-market trading following Q3 results. Credit Suisse reported a profit of Sfr41 million ($42.25 million) for the quarter.
  • Facebook Inc (NASDAQ: FB) shares fell 4.9 percent to $120.91 in the pre-market trading session. Facebook posted better-than-expected earnings for its third quarter on Wednesday. However, the company’s CFO warned that revenue growth rates would decline in the fourth quarter.
  • First Solar, Inc. (NASDAQ: FSLR) fell 4.6 percent to $38.70 in pre-market trading after the company posted weak quarterly revenue and lowered its sales guidance.
  • GoPro Inc (NASDAQ: GPRO) shares fell 4.2 percent to $12.30 in pre-market trading. GoPro is expected to report quarterly earnings after the closing bell.

Posted-In: #PreMarket Gainers LosersNews Movers & Shakers Pre-Market Outlook Markets Movers

 

Related Articles (ACTA + AUPH)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com